A Phase Ib Study ofSingle-AgentIdelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma Article (Web of Science) Early Access (Web of Science)

Industry Collaboration

cited authors

  • Borazanci, Erkut; Pishvaian, Michael J.; Nemunaitis, John; Weekes, Colin; Huang, Julie; Rajakumaraswamy, Nishanthan

publication date

  • June 18, 2020


published in